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Abstract
Mutations in the GJB2 gene, which encodes the gap junction protein connexin 26 (Cx26), are the primary cause of hereditary
prelingual hearing impairment. Here, the p.Cys169Tyr missense mutation of Cx26 (Cx26C169Y), previously classiﬁed as a
polymorphism, has been identiﬁed as causative of severe hearing loss in twoQatari families.Wehave analyzed the effect of this
mutation using a combination of confocal immunoﬂuorescence microscopy and molecular dynamics simulations. At the
cellular level, our results show that the mutant protein fails to form junctional channels in HeLa transfectants despite being
correctly targeted to the plasmamembrane. At themolecular level, this effect can be accounted for by disruption of the disulﬁde
bridge that Cys169 forms with Cys64 in the wild-type structure (Cx26WT). The lack of the disulﬁde bridge in the Cx26C169Y
protein causes a spatial rearrangement of two important residues, Asn176 and Thr177. In the Cx26WT protein, these residues
play a crucial role in the intra-molecular interactions that permit the formation of an intercellular channel by the head-to-head
docking of two opposing hemichannels resident in the plasmamembrane of adjacent cells. Our results elucidate themolecular
pathogenesis of hereditary hearing loss due to the connexinmutation and facilitate the understanding of its role in bothhealthy
and affected individuals.
Received: December 10, 2014. Revised and Accepted: January 21, 2015
© The Author 2015. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
For commercial re-use, please contact journals.permissions@oup.com
Human Molecular Genetics, 2015, Vol. 24, No. 9 2641–2648
doi: 10.1093/hmg/ddv026
Advance Access Publication Date: 26 January 2015
Original Article
2641









Twenty-one genes in the human genome encode connexin pro-
teins (indicated with the abbreviation Cx followed by their mo-
lecular weight in kiloDalton; e.g. Cx26 for the 26 kDa isomer)
with similar structure (1). Connexins are post-translationally oli-
gomerized to form hexameric assemblies, known as connexons
or hemichannels, prior to membrane insertion either within
the endoplasmic reticulum or in the trans-Golgi network. Con-
nexin hemichannels are then trafﬁcked to the plasmamembrane
where thehead-to-headdocking of twohemichannels fromadja-
cent cells promotes the formation of an intercellular channel
with a pore diameter typically >1 nm (2,3). Tens of thousands of
such channels aggregate in a gap junction plaque, allowing cell-
to-cell diffusion of ions and selected metabolites, including se-
cond messengers, amino acids, nucleotides and glucose (4–6).
The importance of electrical and molecular signaling through
gap junction channels is widely recognized (4,7). Plasma mem-
brane hemichannels that remain undocked are thought to rest
in a predominantly closed state. However, they may open transi-
ently in response to a wide range of stimuli permitting the
controlled release of cytoplasmic ATP, glutamate, NAD+, prosta-
glandin E2, glutathione and other paracrine messengers (7),
which are also critical for intercellular communication and the
regulation of key inﬂammatory responses (8).
Consistent with the widespread expression of connexins in
virtually any organ, mutations leading to change in properties,
regulation or expression of connexin-made channels (i.e. hemi-
channels and gap junction channels) have been implicated in a
variety of human diseases, including neuropathies due to de-
myelination of peripheral axons, idiopathic atrial ﬁbrillation, vis-
ceroatrial heterotaxia, cataracts, oculodentodigital dysplasia,
skin disorders and hearing impairment. Up to 50% of prelingual
hearing impairment cases, with peaks reaching 79% amongMed-
iterraneans, have been linked to mutations in GJB2, the gene en-
coding Cx26. This 226-amino acid protein is highly expressed by
non-sensory cells of the inner ear, together with structurally re-
lated connexin 30 (Cx30) (9,10). More than 200 GJB2 mutations,
typically autosomal recessive, have been linked to hereditary
hearing loss (11,12). Cx26 is also expressed in the skin and 18
GJB2 mutations, mostly autosomal-dominant (which typically
produce functional hemichannels with aberrant properties),
have been linked to syndromic deafness associated with derma-
tological manifestations that can be highly invalidating or disﬁg-
uring (13). The only structure resolved at near-atomic resolution
(3.5 Å) is that of a (homomeric homotypic) gap junction channel
formed by human Cx26 protomers (2).
Mutations of connexin expressing genes can affect connexin
hemichannels or gap-junction channels in several ways. Thus,
early truncation of the protein cause profound hearing loss,
whereas missense mutations present more variable phenotypes
since they canmodify the trafﬁcking, the docking between hemi-
channel, the permeation or conductance properties of the chan-
nels or their gating properties (14,15). However, assessing the
pathogenic role of a mutation is not necessarily straightforward,
and GJB2 is no exception.
The p.Cys169Tyr variant of Cx26,ﬁrst described byAzaiez et al.
(16), provides an example in which the effects of a single point
mutation have not been immediately understood. The lack of
segregation with a hearing phenotype in some trios and large
families prompted its classiﬁcation as a polymorphism (17),
and as such, it is currently listed in online databases (e.g. http://
web.expasy.org/variant_pages/VAR_009968.html).
However, the p.Cys169Tyr allele has been recently singled out
in a consanguineous Arabian family from the Middle East; based
on the use of in silico predictor tools, p.Cys169Tyr has been as-
sumed as causative (18). Here, we extended the analysis of this
mutation in the attempt to clarify its possible role and controver-
sial issues associated with the available data.
Results
Sanger sequencing analysis of two Qatari families (a and b) per-
formed on the most common worldwide non-syndromic heredi-
tary hearing loss genes (GJB2, GJB6 and A1555G mitochondrial
mutation) revealed the presence of the c.A506G mutation in the
GJB2 gene, which causes the substitution of a cysteine amino
acid with a tyrosine residue at position 169 of the Cx26 protein
(Cx26C169Y). Family a, previously described in (17), presented
with partial lack of segregation of the p.Cys169Tyr mutation.
Brieﬂy, both parents (obligate carriers) showed normal hearing,
while the four siblings presented moderate-to-severe hearing
loss (Fig. 1). Three patients (II-1, II-2 and II-3) are homozygous
for this allele, while Patient II-4, characterized by severe hearing
loss, is heterozygous, lacking a second GJB2mutated allele. Simi-
larly to Patient II-4 just described in Family a, also in Family b
(a trio), the proband is heterozygous for this allele as well as the
normal hearing father (17). Although this variant was described
by several in silico predictor tools [i.e. MutationTaster (19), Poly-
phen-2 (20) and SIFT (21)] as highly damaging, there was no
clear genotype–phenotype relationship in both families. To fur-
ther understand these ﬁndings, the largest family (a) was in-
cluded in a greatly extended screening of 18 Qatari families
aimed at the identiﬁcation of novel alleles/genes using Linkage
analysis and whole-exome sequencing (WES). Linkage analysis
(following an incomplete penetrance model) revealed a positive
signal only on chromosome 13 in the GJB2 region, while WES
identiﬁed the p.Cys169Tyr mutation as the only possible causa-
tive allele. Within this large screening, another consanguineous
trio (Family c) carrying the same surname and showing the
same phenotype (moderate-to-severe sensorineural bilateral
hearing loss) presented the p.Cys169Tyr mutation of Cx26 segre-
gatingwith the disease. Considering that the Qatari population is
organized in tribes, the presence of the same surname and the
same disease strongly suggests that these two families are
closely related to each other. Altogether these ﬁndings suggest
a possible causative role of the p.Cys169Tyr variant of Cx26.
Cx26 immunolabeling performed in Hela cell
transfectants suggest that Cx26C169Y mutant
connexons fail to form gap junctional plaques
To understand at which level the p.Cys169Tyr mutation affects
the Cx26 protein, we transiently transfected Hela DH cells with
either wild-type or mutant constructs and performed immunos-
taining with antibodies against Cx26 (Fig. 2). In cells overexpres-
sing Cx26WT proteins, gap junction plaques were seen at points
of cell-to-cell contact, with limited intracellular staining. In con-
trast, inHeLaDHcellsoverexpressingmutantCx26C169Yproteins,
the immunoﬂuorescencesignal exhibited apredominantly diffuse
and cytoplasmic localization, with limited staining at the plasma
membrane level. The analysis of confocal through-focus image se-
quences (z-stacks) highlighted the presence of mature junctional
plaques connecting adjacent cells in the Cx26WT transfectants
(Fig. 2A–D). Plaqueswere not observed in themutant transfectants
(Fig. 2F–I). Altogether, these results suggest that a (fraction of the)
Cx26C169Y hemichannels are correctly targeted to the plasma
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membrane, but fail to dock to each other in neighboring cells, thus
preventing the formation of gap junction channels.
Molecular dynamics simulations show signiﬁcant
alteration of the extra cellular domain in the
Cx26C169Ymutant connexon
To corroborate the hypothesis that the p.Cys169Tyr mutation
prevents the formation of Cx26 intercellular channels, we used
molecular dynamics simulations (22–24). In the extracellular
region of the Cx26WT protein, Cys169 forms a (strong covalent)
disulﬁde bond with Cys64, which keeps the distance between
the two sulfur atoms at 2.05 A. In the Cx26C169Y protein, the
p.Cys169Tyr substitution makes the formation of this bond im-
possible and produces an alteration in the distance between resi-
dues 64 and 169 (Fig. 3). The distance between the α carbons of
these residues, averaged over the six connexin subunits of the
connexon, was derived from 100 ns of equilibrium molecular
Figure 1. Pedigree of the families with indication of the phenotypes and the GJB2 genotypes. Pedigree showing three families with Cys169Tyr variants. For Family a,
affected individuals are: II:1 (Cys169Tyr/ Cys169Tyr), II:2 (Cys169Tyr /Cys169Tyr) II:3 (Cys169Tyr/Cys169Tyr) and II:4; (Cys169Tyr /wt); Family b: the proband is II:1
(Cys169Tyr /wt); Family c: the proband is II:1 (C169Y/C169Y). Note: (Cys169Tyr /Cys169Tyr), homozygous; (Cys169Tyr /wt), heterozygous; wt, wild-type.
Figure 2. Cx26 immunostaining performed in Hela DH transfectants overexpressing Cx26WT (top), and Cx26C169Y (bottom) proteins. Through focus confocal image
sequence (z-stack) taken at 0.5 µm intervals of Hela DH cells expressing Cx26WT (A–D) and Cx26C169Y (F–I) proteins and their respective maximal projection
rendering (E and J). Yellow arrow points to representative gap junction plaque, whereas red arrows indicate immunoreaction signals at the cell plasma membrane
level, which are most likely due to unpaired connexons. Scale bar, 10 µm.
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dynamics and plotted as a function time in Figure 4 (left). Figure 4
(right) shows frequency histograms of distance distributions for
thewild-type and themutant connexon. The p.Cys169Tyr substi-
tution modiﬁes the mean value and the variance of these distri-
butions, from 5.9 ± 0.2 Å for the wild-type to 6.6 ± 0.1 Å for the
mutant. Although small, this difference (i) is statistically signiﬁ-
cant (P < 0.0001, Student’s t-test) and (ii) alters the structure of the
hemichannel in the extracellular region (particularly the E2 loop).
Visual inspection of the molecular dynamics trajectories re-
vealed a remarkable deformation affecting two of the proteins
of the hexameric assembly. Albeit less pronounced, deforma-
tions were detectable also in the remaining four connexins.
To keep track of this diversity, we analyzed the trajectory of
each protomer independently. First, we clustered the trajectory
of the six connexins as described in the Materials and Methods
section. Then, for each connexin, we selected one conﬁguration
for the mutant and two conﬁgurations for the wild-type as the
most representative of their respective trajectories. We ﬁnally
computed the root mean squared deviation (RMSD) of the
atoms in the main chain of the seven residues (Asn54, Leu56,
Gln57, Lys168, Asn176, Thr177, Asp179) that are considered re-
sponsible for the extracellular docking of the two connexons
(2), taking the corresponding coordinates of the 3.5 Å X-ray crys-
tallographic structure as reference. Compared with Cx26WT, the
positions of these crucial residues in Cx26C169Y depart signiﬁ-
cantly more from those taken as reference (Fig. 5). The difference
is caused by the displacement of the E2 loop in three of the six
connexins. Indeed, if we concentrate only on residues Asn176
and Thr177, it is clear that the RMSD in three of the six mutant
connexin exceeds 2.5 Å (Fig. 5, red diamonds), whereas the max-
imum RMSD in the wild-type is ∼1.5 Å (Fig. 5, blue squares). We
conclude that such departure from the crystallographic positions
hinders the correct docking of the connexons and prevents the
formation of a full gap junction channel.
Discussion
As is well known, not everyone with a given pathological muta-
tionwill eventually develop a related disease. One of the possible
explanations could be reduced penetrance, but also the presence
ofmodiﬁer genes or other unknown elements in the genomemay
play a role (25). On the other hand, there is a large collection of
variants of unknown signiﬁcance occurring in patients. To assess
the pathogenic role of these mutations, prediction tools are lim-
ited, in that they can only estimate the potential impact of a spe-
ciﬁc variation.
With speciﬁc regard to hereditary hearing loss, the analysis of
several families has revealed a lackof segregation of a given allele
with the clinical status (i.e. carriers who are in some cases
healthy in others affected).
For example, the p.Met34Thr missense mutation of Cx26 was
described ﬁrst as an autosomal-dominantmutation (26), consist-
ent with a subsequent study that reported to exert a dominant-
negative effect over Cx26WT in Xenopus oocyte assays (27).
p.Met34Thr was then re-classiﬁed as a polymorphism on the
basis of contrasting functional data and lack of segregation with
a hearing phenotype in some families (28). Subsequentwork com-
bining genetic, clinical, biochemical, electrophysiological and
Figure 3. Cartoon representation of Cx26WT (left) and Cx26C169Y (right) hemichannels. The six connexins composing the hemichannels are drawn in ribbon; the
extracellular loops (EC1 and EC2) are shown in orange and red (respectively). The insets show details of a single connexin; residues 53–180, 60–174 and 64–169, which
in the wild-type structure are linked by disulﬁde bonds, are drawn in licorice representation.
Figure 4. Distance between residues 64 and 169 during molecular dynamics simulation. The graph on the left shows average distances between α carbons of the two
residues (inset) for the Cx26WT hemichannel (blue) and the Cx26C169Y hemichannel (red) as a function of time. Frequency histograms for the distribution of distance
values are presented in the right panel. The absence of the disulﬁde bridge in the mutant results in a broader distribution, which is also shifted toward larger values.
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structural modeling studies, contributed to re-afﬁrm the patho-
genicity of this allele (22,29). Similarly, the p.Val37Ile variant of
Cx26 has been initially reported as non-pathogenic. However,
further analyses have documented an association of this variant
with mild hearing loss in 9 of 10 genotypic combinations (30), in
accord with other studies of the allele (31–35).
The p.Cys169Tyr variant of Cx26 analyzed here was also
found to segregate only in some families/cases despite being
classiﬁed as highly damaging by in silico predictor tools. Among
the families we analyzed (a, b and c), the genotype–phenotype
discordance and the results of our combined approach (Linkage
andWES studies) showing p.Cys169Tyr of Cx26 as the only causa-
tive variant, prompted us to further investigate its role.
Cys169 is one of the six extracellular cysteine residues which
are conserved in all connexin isoforms. These six cysteines form
three disulﬁde bridges, which are likely to play an important role
in guiding the correct folding of the connexin protein and the dock-
ing of the twohexameric hemichannels in the extracellular region.
In the closely related connexin 32 protein (Cx32), the substitution
of Cys64, which forms the disulﬁde bridge with Cys168 (the analo-
gous of Cys169 in Cx26), with a serine generates a mutant protein
that fails to form gap junction channels, even though it is correctly
targeted to the cell membrane (36). Substitution of any one of the
six cysteines to serine in Cx32 resulted in loss of channel conduct-
ance in paired Xenopus oocyte experiments (37,38).
Our experimental data, based on immunoﬂuorescence of con-
nexin proteins in HeLa DH cell transfectants (Fig. 2), strongly sug-
gest that the mutated protein is correctly trafﬁcked to the plasma
membrane but fails to form gap-junction plaques, conﬁrming that
the extracellular cysteine pattern is fundamental for the docking
of opposing hemichannels. The publication of the Cx26 full chan-
nel X-ray structure (2), and subsequentmolecular dynamics simu-
lations (24) demonstrated that the extracellular domain is rather
stable. The pattern of disulﬁde bonds generated by the six cysteine
residues present in the extracellular loops of Cx26 is clearly central
to maintaining structural stability of this domain.
The analysis of molecular dynamics trajectory presented in
this paper supports the notion that the p.Cys169Tyr mutation
hinders the docking of Cx26 hemichannels by altering protein
structure in the extracellular domain. In particular, we predict a
signiﬁcant displacement of two of the seven amino acids that
are responsible for hemichannel docking, namely Asn176 and
Thr177. It is worth noting that this alteration is not identical in
all six connexins composing this hemichannel (Fig. 5) and, in
some of the protomers, the structure remains virtually unaltered.
We suspect that this discrepancy is due to the relative shortness
of the simulated time span, and that a longer simulation would
lead to similar conﬁgurations in all six connexins. In this vein, al-
though a 100 ns molecular dynamics simulation is sufﬁcient to
re-equilibrate a protein structure in the proximity of a local en-
ergy minimum, detecting a structural rearrangement may re-
quire a longer simulation interval. Nonetheless, our results
strongly suggest the extracellular domain of Cx26 is compro-
mised by the p.Cys169Tyr mutation. In the absence of a co-ex-
pressed Cx26WT protein, or possibly another connexin (e.g.
Cx30), the conformational changewill eventually prevent correct
docking of opposing hemichannels.
In conclusion, we believe that the approach used here eluci-
dates the molecular pathogenesis of hereditary hearing loss
and facilitates the understanding of the p.Cys169Tyr variant of
Cx26 in both healthy and affected individuals. These results
may pave the way to similar analyses of other diseases involving
gap junction proteins.
Materials and Methods
Molecular genetics and audiometry
Aseries of consanguineousQatari familieswere enrolled through
the registry of the National Screening Program for the Early De-
tection of Hearing Loss (NSP-EDHL) at the Audiology Unit of
Hamad Medical Hospital in Doha, Qatar. All patients provided
written informed consent prior to DNA analysis and in the case
of children, the consent was given by the parent/legal guardian.
Hearing tests were performed through tonal audiometry using
air conduction at 250, 500, 1000, 2000, 4000, 6000 and 8000 Hz.
A clinical and dysmorphological examination of the patients
was carried out to exclude non-genetic causes of hearing impair-
ment. All analyzed patients were characterized by non-syndrom-
ic, congenital, sensorineural bilateral mild to severe hearing loss.
Figure 5. The p.Cys169Tyrmutation of Cx26 perturbs also residues that are considered critical for hemichannel docking and formation of a full gap junction channel. The six
left panels show the orientation of side chains of residues Asn176 and Thr177 in the six connexins of themost representative conﬁgurations of wild-type (blue) andmutant
(red) hemichannels. Structural alteration in the extracellular loop due to the absence of one of the disulﬁde bridges alters the position of the side chains of these two critical
residues in themutant hemichannel, which are thought to be responsible of the formation a full gap junction channel. The six panels are ranked in orderof increasing RMSD
ofα carbonsofAsn176 andThr177 fromthe crystal structure of (2). TheRMSDvalues for these two residues are reported in the graphof the right (blue squares for Cx26WT, red
diamonds for Cx26C169Y), together with those of all the seven residues that have been identiﬁed as responsible for the docking in (2): Asn54, Leu56, Gln57, Lys168, Asn176,
Thr177, Asp179 (black triangles for Cx26WT, green circles for Cx26C169Y). The positions of residues Asn176 and Thr177 are the most affected by the mutation. The values
reported for Cx26WT are weighted averages over the two most representative conﬁgurations, as explained in the Materials and Methods section.
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DNAwas extracted from peripheral blood collected in EDTA-con-
taining tubes (Qiagen, USA). The promoter, the coding region and
part of intron 1 (IVS1+1 G to A and -3170 G to A) were tested for
mutations through PCR and Sanger sequencing. The presence
of GJB6 deletion (D13S1830) and themitochondrial A1555Gmuta-
tion were also tested.
Molecular cloning and mutagenesis
The coding region of thewild-type Cx26 was directionally cloned
into the pIRES2 DsRed-Express2 vector between the XhoI/EcoRI
restriction sites. The point mutation c.506G>A, leading to p.Cy-
s169Tyr, was inserted by site-directed mutagenesis of the wild-
type construct using the QuikChange Site-Directed Mutagenesis
Kit (Agilent, Catalog # 200518). The mutagenesis protocol was





The presence of the point mutation in the coding sequence was
veriﬁed by sequencing. No additional mutations were detected.
Cx26 immunoreactivity in Hela cells
Hela DH cells (Sigma, cat. 96112022) were grown in DMEM (Gibco,
catalog no. 41965-039) supplemented with 10% FBS (Gibco, cata-
log no. 10106169), plated on glass coverslips. Using Lipofectamine
3000, cellswere transfectedwith eitherwild-type ormutated con-
nexin constructs in order to overexpress, respectively, Cx26WT
or Cx26C169Y proteins. Twenty-four hours after transfection,
cells were ﬁxed in 2% paraformaldehyde, saturated andpermeabi-
lized for 30 min in BSA 2% Tween 0.1% and incubated over night
with a primary antibody against Cx26 (2.5 µg/ml, Connexin 26
Polyclonal Antibody, Rabbit, Invitrogen Catalog Number 71-0500)
dissolved in BSA 1% (rinse solution). After three washes in
rinse solution, cells were incubated with a secondary antibody
[5 µg/ml, Alexa Fluor® 488 Goat Anti-Rabbit IgG (H+ L), Invitrogen,
Catalog Number A-11008]. After three further washes in rinse
solution, glass coverslips with adherent cells were mounted with
Fluor Save™ Reagent (Calbiochem, Cat # 345789) on a glassmicro-
scope slide. Cell preparations were analyzed using a confocal
microscope (TCS SP5, Leica) equipped with an oil-immersion ob-
jective (63 × HCX PL APO 1.4 N.A., Leica). Laser line intensities
and detector gains were carefully adjusted to minimize signal
bleed through outside the designated spectral windows.
Molecular dynamics simulations
We already generated and published (24) a molecular dynamics
model of a Cx26WT connexon in which the initial α carbon (Cα)
positions were derived from the 3.5 Å X-ray crystallographic
structure (protein data bank entry 2ZW3 (2)). Here, we generated
amodel of the Cx26C169Ymutant connexon froman equilibrium
conﬁguration of the Cx26WT model. To this end, we replaced
Cys169 with a tyrosine in each of the six connexin protomers
using the mutate tool of the Swiss PDB-Viewer (39). We then in-
serted the mutant connexon in a plasma membrane formed by
494 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)
molecules, as described in Pantano et al. (40). To speed up conver-
gence of the interactions between proteins andmembrane, coor-
dinates for the original phospholipid bilayer were obtained from
an equilibrium conﬁguration of the membrane model described
in (41). The system was then solvated with full-atom TIP3P
water. Finally, Cl− and K+ ions were added at a concentration of
∼0.15  to neutralize the positive net charge of the connexon
and to mimic a physiological ionic strength.
For both Cx26WT and Cx26C169Y models, the entire system
comprised > 2 × 105 atoms and was equilibrated by a 100 ns mo-
lecular dynamics simulation using the GROMACS 4.6 software
(42) and the Amber03 force ﬁeld (43) in the NPTensemble. As pre-
viously noted (22–24), a 100 ns simulation is sufﬁcient to achieve
a reasonably stable state. Temperature Tandpressure Pwere kept
constant, at 300 K and 1 atm, respectively, using the Berendsen
thermostat and barostat (44). Fast smooth Particle-Mesh Ewald
summation (45) was used for long-range electrostatic interac-
tions, with a cut-off of 1.0 nm for the direct interactions. Simula-
tions were performed under periodic boundary conditions using
unitary boxes of 12 × 12 × 11 nm for both systems, consistentwith
the channel density measured in a Cx26 gap-junction plaque by
atomic force microscopy (46).
Clustering of atomic conﬁgurations
A consolidated technique used to analyze long molecular dy-
namics trajectory and reduce data complexity while retaining
the relevant information consists in clustering atomic conﬁgura-
tions using suitable metrics (47). Here, clusters were obtained
with the g_cluster tool of GROMACS 4.6 by restricting the analysis
to the two extracellular loops (residues 41–75 and 155–192) of the
six different connexins. Each cluster contained all the conﬁgura-
tions for which the RMSD of the corresponding main-chain
atoms was ≤1.1 Å. For the Cx26C169Ymodel, the single most im-
portant cluster contained 69.8% of the MD trajectory. For the
Cx26WT model, instead, we obtained two principal clusters re-
presenting 46.0 and 17.0% of the conﬁgurations, respectively.
The mean values of the observables reported in the Results sec-
tion for Cx26WT are weighted averages of these two clusters,
with weights proportional to the percentage of trajectory
covered.
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